Sodium-glucose co-transporter 2 inhibition: the saga continues

Eur Heart J. 2022 Nov 1;43(41):4215-4218. doi: 10.1093/eurheartj/ehac590.

Author

Filippo Crea^{1

2}

Affiliations

¹ Department of Cardiovascular Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
² Department of Cardiovascular and Pulmonary Sciences, Catholic University of the Sacred Heart, Rome, Italy.

PMID: 36316017
DOI: 10.1093/eurheartj/ehac590

No abstract available

MeSH terms

Diabetes Mellitus, Type 2* / drug therapy
Glucose
Humans
Hypoglycemic Agents / pharmacology
Hypoglycemic Agents / therapeutic use
Sodium
Sodium-Glucose Transporter 2
Sodium-Glucose Transporter 2 Inhibitors* / pharmacology
Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use

Substances

Sodium-Glucose Transporter 2
Sodium-Glucose Transporter 2 Inhibitors
Hypoglycemic Agents
Glucose
Sodium